Detection of heteroresistant Mycobacterium tuberculosis by pyrosequencing

Journal of Clinical Microbiology

Volumn 51, Issue 12, 2013, Pages 4210-4212

  Engström, Anna ^a,b   Hoffner, Sven ^a,b   Juréen, Pontus ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM MUTANT; CONTROLLED STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PYROSEQUENCING; RPOB GENE; SENSITIVITY ANALYSIS; WILD TYPE;

DRUG RESISTANCE, BACTERIAL; GENETICS, POPULATION; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS;

EID: 84889834845     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01761-13     Document Type: Article

References (18)

1. World Health Organization. 2012. Global report on tuberculosis 2012, vol WHO/HTM/TB/2012.6, Geneva, Switzerland.
2. Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, Safi H, Blakemore R, Lan NT, Jones-Lopez EC, Levi M, Burday M, Ayakaka I, Mugerwa RD, McMillan B, Winn- Deen E, Christel L, Dailey P, Perkins MD, Persing DH, Alland D. 2010. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J. Clin. Microbiol. 48: 229-237.
3. Hillemann D, Rusch-Gerdes S, Richter E. 2009. Feasibility of the Geno- Type MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 47:1767-1772.
4. Hillemann D, Rusch-Gerdes S, Richter E. 2007. Evaluation of the Geno- Type MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 45:2635-2640.
5. Engström A, Morcillo N, Imperiale B, Hoffner SE, Jureen P. 2012. Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing. J. Clin. Microbiol. 50: 2026-2033.
6. Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Metchock B, Starks AM, Hooks DP, Cowan LS, Plikaytis BB, Posey JE. 2011. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 55:2032-2041.
7. Therese KL, Gayathri R, Madhavan HN. 2012. Molecular biological techniques for detection of multidrug resistant tuberculosis (MDR) and extremely drug resistant tuberculosis (XDR) in clinical isolates of Mycobacterium tuberculosis, p. 455-470. In Cardona P-J (ed), Understanding tuberculosis- global experiences and innovative approaches to the diagnosis. InTech, Rijeka, Croatia.
8. Rinder H, Mieskes KT, Loscher T. 2001. Heteroresistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 5:339-345.
9. Hofmann-Thiel S, van Ingen J, Feldmann K, Turaev L, Uzakova GT, Murmusaeva G, van Soolingen D, Hoffmann H. 2009. Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan. Eur. Respir. J. 33:368-374.
10. Chakravorty S, Kothari H, Aladegbami B, Cho EJ, Lee JS, Roh SS, Kim H, Kwak H, Lee EG, Hwang SH, Banada PP, Safi H, Via LE, Cho SN, Barry CE, III, Alland D. 2012. Rapid, high-throughput detection of rifampin resistance and heteroresistance in Mycobacterium tuberculosis by use of sloppy molecular beacon melting temperature coding. J. Clin. Microbiol. 50:2194-2202.
11. Bigger JW. 1944. Treatment of staphylococcal infections with penicillin. Lancet 244:497-500.
12. Jureen P, Engstrand L, Eriksson S, Alderborn A, Krabbe M, Hoffner SE. 2006. Rapid detection of rifampin resistance in Mycobacterium tuberculosis by pyrosequencing technology. J. Clin. Microbiol. 44:1925-1929.
13. Martin A, Paasch F, Docx S, Fissette K, Imperiale B, Ribon W, Gonzalez LA, Werngren J, Engström A, Skenders G, Jureen P, Hoffner S, Del Portillo P, Morcillo N, Palomino JC. 2011. Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis. J. Antimicrob. Chemother. 66:827-833.
14. Lindstrom A, Odeberg J, Albert J. 2004. Pyrosequencing for detection of lamivudine-resistant hepatitis B virus. J. Clin. Microbiol. 42:4788-4795.
15. Blakemore R, Story E, Helb D, Kop J, Banada P, Owens MR, Chakravorty S, Jones M, Alland D. 2010. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J. Clin. Microbiol. 48:2495-2501.
16. Folkvardsen DB, Svensson E, Thomsen VO, Rasmussen EM, Bang D, Werngren J, Hoffner S, Hillemann D, Rigouts L. 2013. Can molecular methods detect 1% isoniazid resistance in Mycobacterium tuberculosis? J. Clin. Microbiol. 51:1596-1599.
17. Meldrum C, Doyle MA, Tothill RW. 2011. Next-generation sequencing for cancer diagnostics: a practical perspective. Clin. Biochem. Rev. 32: 177-195.
18. Pholwat S, Stroup S, Foongladda S, Houpt E. 2013. Digital PCR to detect and quantify heteroresistance in drug resistant Mycobacterium tuberculosis. PLoS One 8:e57238. doi:10.1371/journal.pone.0057238.